GSK, SK to compare COVID-19 vaccine candidate to AZ’s jab
Phase III trial will use AZ’s COVID-19 vaccine as an active comparator
Read More
Tag: SK bioscience
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
